Skip to main content
Cognitive DysfunctionCognitive functionBrain and nervesDevice

What this study is

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.

What's being tested

  • Fareon device

    Intervention · DEVICE

    Participants will use the device 2 times per week for 15 minutes at home.

Study details

Official title
Microtesla Magnetic Therapy (MMT) Treatment of Cognitive Impairment: Open Label Pilot Study
Sponsor
Icahn School of Medicine at Mount Sinai
Conditions
Cognitive Dysfunction · Acquired Brain Injury · Traumatic Brain Injury
Enrolling
30 people
Starts
2026-05-11
Est. completion
2027-04-30
Design
Open-label, single group
Record
View on ClinicalTrials.gov ↗